Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 3018 (LINC03018) is a member of the long non-coding RNA (lncRNA) class, specifically classified as a long intergenic non-coding RNA (lincRNA)[1][5]. LINC03018 does **not** code for a protein; instead, like other lincRNAs, it represents a transcript of over 200 nucleotides that originates in genomic regions distant from protein-coding genes[3][9]. LincRNAs are known to play broad roles in the regulation of transcription, chromatin structure, and gene expression, often by acting as scaffolds for chromatin-modifying complexes or by regulating neighboring or distant genes at the transcriptional or post-transcriptional level[3][7][9]. While dysregulation of lncRNAs is implicated in various diseases—most notably cancer, cardiovascular, neurodegenerative, and immune conditions—LINC03018 itself currently lacks reported direct evidence for a therapeutic target role or specific interacting drugs, and its specific biological activities and disease involvements remain largely uncharacterized in the literature[1][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 3018 (LINC03018).